Cerebral ischemia, cell cycle elements and Cdk5

Biotechnology Journal

Volumn 2, Issue 8, 2007, Pages 958-966

  Timsit, Serge ^a   Menn, Bénédicte ^b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b Turing Center for Living Systems CENTURI Aix Marseille University   (France)

Author keywords

Cdk5; Cerebral ischemia; Cyclin; Neuronal death; Stroke

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 5 INHIBITOR; CYCLIN E; CYCLINE; FLAVONOID; FLAVOPIRIDOL; INDOLINOL A; OLOMOUCINE; PAULLONE; PROTEIN KINASE INHIBITOR; PROTEIN P25; PROTEIN P35; PURINE DERIVATIVE; RETINOBLASTOMA PROTEIN; ROSCOVITINE; STAUROSPORINE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; CDK5 PROTEIN, HUMAN; CELL CYCLE PROTEIN; NERVE PROTEIN;

BRAIN ISCHEMIA; CELL CYCLE ARREST; CELL CYCLE REGULATION; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXCITOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINA ISCHEMIA; REVIEW; SPINAL CORD ISCHEMIA; ANIMAL; BRAIN; CELL CYCLE; ENZYMOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE 5; HUMANS; NERVE TISSUE PROTEINS;

EID: 34548513529     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700072     Document Type: Review

References (83)

1. Khaja, A. M., Grotta, J. C., Established treatments for acute ischaemic stroke. Lancet 2007, 369, 319-330.
2. Sacco, R. L., Chong, J. Y., Prabhakaran S., Ellkind, M. S., Experimental treatments for acute ischemic stroke. Lancet 2007, 369, 331-341.
3. + at critical levels of brain ischemia. Stroke 1977, 8, 51-57.
4. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B. et al., Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15, 961-973.
5. Nicotera, P., Leist, M., Ferrando-May, E., Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. 1999, 66, 69-73.
6. Nicotera, P., Apoptosis and age-related disorders: role of caspasa-dependant and caspase-independent pathways. Toxicol. Lett. 2002, 127, 189-195.
7. Sugawara, T., Fujimura, M., Noshita, N., Kim, G. W. et al., Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 2004, 1, 17-26.
8. Bredesen, D. E., Toward a mechanistic taxonomy for cell death programs. Stroke 2007, 38, 652-660.
9. Fisher, M., Characterizing the target of acute stroke therapy. Stroke 1997, 28, 866-872.
10. Choi, D. W., Calcium-mediated neurotoxicity: relationship to specific channels types and role in ischemic damage. Trends Neurosci. 1988, 11, 465-469.
11. Coyle, J. T., Puttfarcken, P., Oxidative stress, glutamate and neurodegenerative disorders. Science 1993, 262, 689-695.
12. Lipton, S. A., Rosenberg, P. A., Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994, 330, 613-622.
13. Portera-Cailliau, C., Price, D. L., Martin, L. J., Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 1997, 378, 88-104.
14. Hoyte, L., Kaur, J., Buchan, A. M., Lost in translation: taking neuroprotection from animal models to clinical trials. Exp. Neurol. 2004, 188, 200-204.
15. Tamura, A., Graham, D. I., McCulloch, J., Teasdale, G. M., Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1981, 1, 53-60.
16. Guegan, C., Ceballos-Picot, I., Nicole, A., Kato, H. et al., Recruitment of several neuroprotective pathways after permanent focal ischemia in mice. Exp. Neurol. 1998, 154, 371-380.
17. Hata, R., Maeda, K., Hermann, D., Mies, G. et al., Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J. Cereb. Flow Metab. 2000, 20, 306-315.
18. Benchoua, A., Guegan, C., Couriaud, C., Hosseini, H. et al., Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 2001, 21, 7127-7134.
19. Heintz, N., Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem. 1993, 18, 157-159.
20. Khrestchatisky, M., Timsit, S., Rivera, S., Tremblay, E. et al., Neuronal death end damage repair: roles of proto-oncogenes and cell cycle-related proteins, In: J. Krieglstein (Ed.), Pharmacology of Cerebral Ischemia, Medpharm Scientific, Stuttgart 1996, pp. 41-56.
21. Park, D. S., Obeidat, A., Giovanni, A., Greene, L. A., Cell cycle regulator in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol. Aging. 2000, 21, 771-781.
22. Sherr, C. J., G1 cyclins. Cell 1993, 73, 1059-1065.
23. Dhavan, R., Tsai, L. H., A decade of CDK5. Nat. Rev. Mol. Cell. Biol. 2001, 2, 749-759.
24. Benavides, D. R., Bibb, J. A., Role of Cdk5 in drug abuse and plasticity. Ann. N. Y. Acad. Sci. 2004, 1025, 335-344.
25. Shelton, S. B., Johnson, G. V., Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 2004, 88, 1313-1326.
26. Weishaupt, J. H., Neusch, C., Bahr, M., Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res. 2003, 312, 1-8.
27. Cheung, Z. H., Fu, A. K., Ip, N. Y., Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases. Neuron 2006, 50, 13-18.
28. Cruz, J. C., Tsai, L. H., A Jekyll and Hyde kinase: roles for Cdk5 in brain. Curr. Opin. Neurobiol. 2004, 14, 390-394.
29. Ahuja, H. S., Zhu, Y., Zakeri, Z., Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death. Dev. Genet. 1997, 21, 258-267.
30. Zhang, Q., Ahuja, H. S., Zakeri, Z. F., Wolgemuth, D. J., Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev. Biol. 1997, 183, 222-33.
31. Henchcliffe, C., Burke, R. E., Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra. Neurosci. Lett. 1997, 230, 41-44.
32. Bajaj, N. P., Al-Sarraj, S. T., Anderson, V., Kibble, M. et al., Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci. Lett. 1998, 245, 45-48.
33. Giardina, S. F., Cheung, N. S., Reid, M. T., Beart, P. M., Kainate-induced apoptosis in cultured murine cerebellar granule cells elevates expression of the cell cycle gene cyclin D1. J. Neurochem. 1998, 71, 1325-1328.
34. Verdaguer, E., Garcia-Jorda, E., Canudas, A. M., Dominguez, E. et al., Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. Neuroreport 2002, 13, 413-416.
35. Katchanov, J., Harms, C., Gertz, K., Hauck, L. et al., Mild cerebral ischemia induces loss of cyclin-dependant kinase inhibitors and activation of cell cycle machinery before delayed neuronal death. J. Neurosci. 2001, 21, 5045-5053.
36. Rashidian, J., Iyirhiaro, G., Aleyasin, H., Rios, M. et al., Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2005, 102, 14080-14085.
37. Smith, R. A., Walker, T., Xie, X., Hou, S. T., Involvement of the transcription factor e2f1/Rb in kainic acid-induced death of murine carebellar granule cells, Brain Res. Mol. Brain Res. 2003, 116, 70-79.
38. Gendron, T. F., Mealing, G. A., Paris, J., Lou, A. et al., Attenuation of neurotoxicity in cortical cultures and hippocampal slices from e2f1 knockout mice. J. Neurochem. 2001, 78, 315-324.
39. Ming-sum, L., Kwon, Y. T., Mingwei, L., Peng, J. et al., Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405, 360-364.
40. Knockaert, M., Greengard, P., Meijer, L., Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 2002, 23, 417-425.
41. Noble, M. E., Endicott, J. A., Johnson, L. N., Protein kinase inhibitors: insights into drug design from structure. Science 2004, 303, 1800-1806.
42. Mapelli, M., Massimiliano, L., Crovace, C., Seeliger, M. A. et al., Mechanism of CDK5/p25 binding by CDX inhibitors. J. Med. Chem. 2005, 48, 671-679.
43. Bach, S., Knockaert, M., Reinhardt, J., Lozach, O. et al., Roscovitine targets, protein kinases and pyridoxal kinase. J. Biol. Chem. 2005, 280, 31208-31219.
44. Giardina, S. F., Beart, P. M., Kainate receptor-mediated apoptosis in primary cultures of cerebellar granule cells is attenuated by mitogen-activated protein and cyclin-dependent kinase inhibitors. Br. J. Pharmacol. 2002, 135, 1723-1742.
45. Meijer, L., Borgne, A., Mulner, O., Chong, J. P. et al., Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 1997, 243, 527-536.
46. Verdaguer, E., Jimenez, A., Canudas, A. M., Jorda, E. G. et al., Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment, J. Pharmacol. Exp. Ther. 2004, 308, 609-616.
47. Monaco, E. A. 3rd, Beaman-Hall, C. M., Mathur, A., Vallano, M. L., Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons. Biochem. Pharmacol. 2004, 67, 1947-1964.
48. Wiessner, C., Brink, I., Lorenz, P., Neumann-Haefelin, T. et al., Cyclin D1 messenger RNA is induced in microglia rather than neurons following transient forebrain ischaemia. Neuroscience 1996, 72, 947-958.
49. Timsit, S., Rivera, S., Ouaghi, P., Guischard, F. et al., Increased cyclin D1 expression in dying neurons after ischemia provides a link between in vivo programmed cell death and cell cycle Eur. J. Neurosci. 1999, 11, 263-278.
50. Small, D. L., Monette, R., Fournier, M. C., Zurakowski, B. et al., Characterization of cyclin D1 expression in a rat global model of cerebral ischemma. Brain Res. 2001, 900, 26-37.
51. Kato, H, Takahashi, A, Itoyama, Y., Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Res. Bull. 2003, 60, 215-221.
52. Wang, F., Corbett, D., Osuga, H., Osuga, S. et al., Inhibition of cyclin-dependent kinases improves CA1 neuronal survival and behavioral performance alter global ischemia in the rat. J. Cereb. Blood Flow Metab. 2002, 22, 171-182.
53. Love, S., Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neurosci. Lett. 2003, 353, 29-32.
54. Green, S. L., Kulp, K. S., Vulliet, R., Cyclin-dependant kinase 5 activity increases in rat brain following ischemia. Neurochem. Int. 1997, 31, 617-623.
55. Morioka, M., Kawano, T., Yano, S., Kai, Y., Tsuiki H. et al., Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Biochem. Biophys. Res. Commun. 2006, 347, 273-278.
56. Guegan, C., Levy, V., David, J. P., Ajchenbaum-Cymbalista, F. et al., c-Jun and cyclin D1 proteins as mediators of neuronal death after a focal ischaemic insult. Neuroreport. 1997, 8, 1003-1007.
57. Li, Y., Jiang, N., Powers, C., Chopp, M., Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 1998, 29, 1972-1960.
58. Osuga, H., Osuga, S., Wang, F., Fetni, R., et al., Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. USA 2000, 97, 10254-10259.
59. Hayashi, T., Sakurai, M., Abe, K., Itoyama, Y., DNA fragmentation precedes aberrant expression of cell cycle-related protein in rat brain after MCA occlusion. Neurol. Res. 1999, 21, 695-698.
60. Wen, Y., Yang, S., Liu, R., Simpkins, J. W., Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett. 2005, 579, 4591-4599.
61. Zhu, Z., Zhang, Q., Yu, Z., Zhang, L. et al., Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo. Glia 2007, 55, 546-558.
62. MacManus, J. P., Koch, C. J., Jian, M., Walker, T. et al., Decreased brain infarct following focal ischemia in mice lacking the transcription factor E2F1. Neuroreport 1999, 10, 2711-2714.
63. MacMenus, J. P., Jian, M., Preston, E., Rasquinha, I et al., Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice. J. Cereb. Blood Flow Metab. 2003, 23, 1020-1028.
64. Wang, J., Liu, S. H., Fu, Y. P., Wang, J. H. et al., Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 2003, 6, 1039-1047.
65. Wen, Y., Yang, S. H., Liu, R., Perez, E. J. et al., Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim. Biophys. Acta 2006, 1772, 473-483.
66. Weishaupt, J. H., Kussmaul, L., Grotsch, P., Heckel, A. et al., Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction. Mol. Cell. Neurosci. 2003, 24, 489-502.
67. Sakurai, M., Hayashi, T., Abe, K., Itoyama, Y. et al., Cyclin D1 and Cdk4 protein induction in motor neurons after transient spinal cord ischemia in rabbits. Stroke 2000, 31, 200-207.
68. Kuroiwa, S., Katai, N., Shibuki, H., Kurokawa, T. et al., Expression of cell cycle-related genes in dying cells in retinal ischemic injury. Invest. Ophthalmol. Vis. Sci. 1998, 39, 610-617.
69. Ino, H., Chiba, T., Cyclin-dependant kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J. Neurosci. 2001, 21, 6086-6094.
70. Nguyen, M. D., Mushynski, W. E., Julien, J. P., Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ. 2002, 9, 1294-1306.
71. Camins, A., Verdaguer, E., Folch, J., Canudas, A. M. et al., The role of CDK5/P25 formation/inhibition in neurodegeneration. Drug News Perspect. 2006, 19, 453-460.
72. Hamdane, M., Bretteville, A., Sambo, A. V., Schindowski, K. et al., p26/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J. Cell Sci. 2005, 118, 1291-1298.
73. Liu, J., Kipreos, E. T., Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAK5 in yeast and metazoa. Mol. Biol. Evol. 2000, 17, 1061-1074.
74. Xiong, Y., Zhang, H., Beach, D., D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992, 71, 506-514.
75. Zhang, H., Xiong, Y., Beach, D., Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 1993, 4, 897-906.
76. Miyajima, M., Nornes, H. O., Neuman, T., Cyclin E is expressed in neurons and forms complexes with cdk5. Neuroreport 1995, 6, 1130-1132.
77. Cicero, C., Herrup, K., Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J. Neurosci. 2005, 25, 9658-9668.
78. Cheng, K., Ip, N. Y., CDK5: a new player at synapses. Neurosignals 2003, 12, 180-190.
79. Angelo, M., Plattner, F., Giese, K. P., Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J. Neurochem. 2006, 99, 353-370.
80. Li, B. S., Sun, M. K., Zhang, L., Takahashi, S. et al., Regulation of NMDA receptor by cyclin-dependant kinase-5. Proc. Natl. Acad. Sci. USA 2001, 98, 12742-12747.
81. Morabito, M. A., Sheng, M., Tsai, L. H., Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 2004, 24, 865-876.
82. Rashidian, J., Iyirhiaro, G. O., Park, D. S., Cell cycle machinery and stroke. Biochim. Biophys. Acta 2007, 4, 484-493.
83. Fisher, M., Davalos, A., Rogalewski, A., Schneider A. et al., Toward a multimodal neuroprotective treament of stroke. Stroke 2006, 37, 1129-1136.